erythromycin has been researched along with floxacillin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (33.33) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Lacey, RW; Lewis, EL | 1 |
| Wilkinson, PM | 1 |
| Hadderingh, RJ; Hulsebosch, HJ; Lange, JM; Reiss, P; van der Wouw, PA; Walford, N | 1 |
| Holmes, AM; Morton, AR; Waldek, S | 1 |
| Ah Chan, M; Fetherston, J; Hague, IK; Haycock, D; Hunter, P; Kanji, K; Robertson, WD; Villiger, JW | 1 |
| Baig, A; Grillage, MG; Welch, RB | 1 |
| Dorman, DC; Gapes, M; Ly, J; Rogers, M | 1 |
| Close, DM; Guinness, MD | 1 |
| Lant, AF; McNabb, WR; Shanson, DC; Williams, TD | 1 |
| Finnie, IA; Jack, CI; McKay, JS | 1 |
| Martin, A; Milgram, E; Pérez-Gutiérrez, F; Prosperi, J; Rodriguez-Solares, A | 1 |
| Pillans, PI | 1 |
| Pulverer, G; Rump, A; Schierholz, JM | 1 |
| Abeck, D; Korting, HC; Neubert, U | 1 |
| Macfarlane, JT; Tang, CM | 1 |
| Bryant, J; Gisby, J | 1 |
| Bagg, J; Gibson, J; Wray, D | 1 |
| Holm, M; Tärnvik, A | 1 |
| Coghlan, KM; Hardee, PG; Misra, D | 1 |
3 trial(s) available for erythromycin and floxacillin
| Article | Year |
|---|---|
A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Topics: Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Erythromycin; Fatty Acids; Female; Floxacillin; Humans; Infant; Male; Mupirocin; Random Allocation; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1986 |
A comparison of erythromycin and flucloxacillin in the treatment of infected skin lesions in general practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cloxacillin; Erythromycin; Female; Floxacillin; Humans; Male; Middle Aged; Skin Diseases, Infectious; Tablets, Enteric-Coated | 1988 |
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
Topics: Azithromycin; Child; Child, Preschool; Dicloxacillin; Drug Administration Schedule; Erythromycin; Floxacillin; Humans; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1993 |
24 other study(ies) available for erythromycin and floxacillin
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Further evolution of a strain of Staphylococcus aureus in vivo: evidence for significant inactivation of flucloxacillin by penicillinase.
Topics: Ampicillin; Clindamycin; Cloxacillin; Erythromycin; Floxacillin; Fusidic Acid; Genes; Genetic Linkage; Hemolysin Proteins; Humans; Lincomycin; Lung Diseases; Mutation; Penicillin Resistance; Penicillinase; Phenotype; Plasmids; Sputum; Staphylococcal Infections; Staphylococcus; Virulence | 1975 |
Clinical pharmacology of antibiotic therapy.
Topics: Aminoglycosides; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalexin; Cephaloridine; Cephalothin; Chloramphenicol; Clindamycin; Cloxacillin; Creatinine; Drug Therapy, Combination; Erythromycin; Floxacillin; Gentamicins; Humans; Kidney Diseases; Lincomycin; Methicillin; Penicillin G; Penicillins; Tetracyclines | 1976 |
Disseminated cat-scratch disease in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cat-Scratch Disease; Erythromycin; Floxacillin; Humans; Male; Opportunistic Infections; Vancomycin | 1989 |
Management of exit-site infections during continuous ambulatory peritoneal dialysis.
Topics: Catheters, Indwelling; Drug Therapy, Combination; Erythromycin; Floxacillin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Retrospective Studies; Rifampin; Staphylococcal Infections | 1987 |
A three-year study of impetigo in Sydney.
Topics: Adolescent; Australia; Child; Child, Preschool; Erythromycin; Floxacillin; Humans; Impetigo; Infant; Penicillin Resistance; Penicillins; Seasons; Staphylococcus aureus; Streptococcus pyogenes | 1987 |
Abscess of the nasal septum after trauma.
Topics: Abscess; Adult; Child, Preschool; Cloxacillin; Erythromycin; Floxacillin; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Nasal Septum; Pneumococcal Infections; Regeneration; Staphylococcal Infections | 1985 |
Erythromycin compared with a combination of ampicillin plus flucloxacillin for the treatment of community acquired pneumonia in adults.
Topics: Adult; Aged; Ampicillin; Cloxacillin; Drug Combinations; Erythromycin; Female; Floxacillin; Humans; Male; Middle Aged; Pneumonia; Time Factors | 1984 |
Pneumomediastinum and subcutaneous emphysema complicating staphylococcal pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Erythromycin; Female; Floxacillin; Humans; Mediastinal Emphysema; Penicillins; Pneumonia, Staphylococcal; Radiography; Subcutaneous Emphysema | 1995 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Drug delivery concepts for the efficacious prevention of foreign-body infections.
Topics: Ciprofloxacin; Drug Carriers; Erythromycin; Floxacillin; Microbial Sensitivity Tests; Oxacillin; Polyurethanes; Rifampin; Silicones; Staphylococcus epidermidis | 1996 |
Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Erythromycin; Floxacillin; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Pseudomonas; Skin; Staphylococcus aureus; Streptococcaceae; Tetracycline | 1998 |
Early management of younger adults dying of community acquired pneumonia.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Carbon Dioxide; Catchment Area, Health; Chronic Disease; Community-Acquired Infections; Critical Care; England; Erythromycin; Female; Floxacillin; Humans; Male; Middle Aged; Oxygen; Patient Admission; Penicillins; Pneumonia; Referral and Consultation; Retrospective Studies | 1993 |
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection | 2000 |
Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Crohn Disease; Erythromycin; Face; Female; Floxacillin; Granuloma; Humans; Male; Mouth Mucosa; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Stomatitis | 2000 |
Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Bites and Stings; Cats; Cefadroxil; Cephalosporins; Child; Child, Preschool; Dogs; Erythromycin; Female; Floxacillin; Hospitalization; Humans; Male; Medication Errors; Middle Aged; Pasteurella Infections; Pasteurella multocida; Penicillin V; Penicillins; Retrospective Studies; Wound Infection | 2000 |
Staphylococcal submandibular lymphadentitis of childhood.
Topics: Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Child; Drainage; Erythromycin; Female; Floxacillin; Focal Infection, Dental; Gentamicins; Humans; Infant; Injections, Intravenous; Lymph Nodes; Lymphadenitis; Neck; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2001 |